Theaflavin

Theaflavin
Product Name Theaflavin
CAS No.: 4670-05-7
Catalog No.: CFN98597
Molecular Formula: C29H24O12
Molecular Weight: 564.49 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Targets: Antifection | ROS | TNF-α | NF-kB | IL Receptor | IkB | ERK | JNK | p38MAPK | Caspase | AMPK | IKK | H1N1 | HSV-1 | MCP-1 | ICAM-1 | FAS
Source: The leaves of Camellia sinensis (L.) O. Kuntze.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $268/20mg
Theaflavin is a suitable natural inhibitor against influenza A (H1N1) neuraminidase, which has anti-inflammatory, antioxidative, anti-mutagenic, anti-HSV-1, and anti-carcinogenic properties. Theaflavin is active in the prevention of fatty liver and obesity, it can significantly reduce lipid accumulation, suppress fatty acid synthesis, and stimulate fatty acid oxidation. Theaflavin inhibits LPS-Induced IL-6, MCP-1, and ICAM-1 expression in bone marrow-derived macrophages through the blockade of NF-κB and MAPK signaling pathways; it also protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • J Med Food.2020, 23(6):633-640.
  • J Ethnopharmacol.2022, 282:114574.
  • Anal Biochem.2019, 569:10-15
  • J Holistic Integrative Pharm.2023, 4(1):14-28
  • Int J Oncol.2019, 55(1):320-330
  • Evid Based Complement Alternat Med.2018, 2018:8565132
  • Applied Biological Chemistry2022, 71:s13765-022-00743-5.
  • Antioxidants.2022, 11(4), 67.
  • Int J Food Sci Nutr.2019, 70(7):825-833
  • Biomolecules2021, 11(10),1513.
  • Theaflavin

    Catalog No: CFN98597
    CAS No: 4670-05-7
    Price: $268/20mg
    Theaflavin-3'-gallate

    Catalog No: CFN98599
    CAS No: 28543-07-9
    Price: $458/20mg
    Theaflavin-3-gallate

    Catalog No: CFN90170
    CAS No: 30462-34-1
    Price: $388/20mg
    Theaflavin 3,3'-di-O-gallate

    Catalog No: CFN99130
    CAS No: 30462-35-2
    Price: $268/20mg
    (2R)-8-Methylsocotrin-4'-ol

    Catalog No: CFN92834
    CAS No: 956103-75-6
    Price: Inquiry(manager@chemfaces.com)
    Dracoflavan A

    Catalog No: CFN92681
    CAS No: 132185-42-3
    Price: Inquiry(manager@chemfaces.com)
    Chamaechromone

    Catalog No: CFN92815
    CAS No: 93413-00-4
    Price: Inquiry(manager@chemfaces.com)
    J Microbiol Biotechnol. 2013 Sep 28;23(9):1322-6.
    Antifungal synergy of theaflavin and epicatechin combinations against Candida albicans.[Pubmed: 23711519]
    New antifungal agents are required to compensate for the increase in resistance to standard antifungal agents of Candida albicans, which is an important opportunistic fungal pathogen that causes minor infections in many individuals but very serious infections in those who are immune-compromised.
    METHODS AND RESULTS:
    In this study, combinations of Theaflavin and epicatechin are investigated as potential antifungal agents and also to establish whether antifungal synergy exists between these two readily accessible and cost-effective polyphenols isolated from black and green tea. The results of disc diffusion assays showed stronger antibacterial activity of Theaflavin:epicatechin combinations against C. albicans NCTC 3255 and NCTC 3179, than that of Theaflavin alone. Minimum inhibitory concentrations (MICs) of 1,024 μg/ml with Theaflavin and 128-256 μg/ml with Theaflavin:epicatechin combinations were found. The fractional inhibitory concentration indexes were calculated, and the synergy between Theaflavin and epicatechin against both isolates of C. albicans was confirmed.
    CONCLUSIONS:
    Theaflavin:epicatechin combinations show real potential for future use as a treatment for infections caused by C. albicans.
    Genomics Inform . 2016 Sep;14(3):96-103.
    Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking[Pubmed: 27729839]
    Abstract The influenza A (H1N1) virus, also known as swine flu is a leading cause of morbidity and mortality since 2009. There is a need to explore novel anti-viral drugs for overcoming the epidemics. Traditionally, different plant extracts of garlic, ginger, kalmegh, ajwain, green tea, turmeric, menthe, tulsi, etc. have been used as hopeful source of prevention and treatment of human influenza. The H1N1 virus contains an important glycoprotein, known as neuraminidase (NA) that is mainly responsible for initiation of viral infection and is essential for the life cycle of H1N1. It is responsible for sialic acid cleavage from glycans of the infected cell. We employed amino acid sequence of H1N1 NA to predict the tertiary structure using Phyre2 server and validated using ProCheck, ProSA, ProQ, and ERRAT server. Further, the modelled structure was docked with thirteen natural compounds of plant origin using AutoDock4.2. Most of the natural compounds showed effective inhibitory activity against H1N1 NA in binding condition. This study also highlights interaction of these natural inhibitors with amino residues of NA protein. Furthermore, among 13 natural compounds, Theaflavin, found in green tea, was observed to inhibit H1N1 NA proteins strongly supported by lowest docking energy. Hence, it may be of interest to consider Theaflavin for further in vitro and in vivo evaluation. Keywords: influenza A Virus; molecular docking analysis; neuraminidase; phytochemicals.
    Biochem Biophys Res Commun. 2012 Jan 6;417(1):287-93.
    Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model.[Pubmed: 22155236]
    The incidence of non-alcoholic fatty liver disease (NAFLD) has been increasing, and there is a shortage of liver donors, which has led to the acceptance of steatotic livers for transplantation. However, steatotic livers are known to experience more severe acute ischemia-reperfusion (I/R) injury than normal livers upon transplantation. In the present study, we investigated the role of Theaflavin, a polyphenol substance extracted from black tea, in attenuating acute I/R injury in a fatty liver model.
    METHODS AND RESULTS:
    We induced I/R in normal and steatotic livers treated with or without Theaflavin. We also separated primary hepatocytes from the normal and steatotic livers, and applied RAW264.7 cells, a mouse macrophage cell line, that was pretreated with Theaflavin. We observed that liver steatosis, oxidative stress, inflammation and hepatocyte apoptosis were increased in the steatotic liver compared to the normal liver, however, these changes were significantly decreased by Theaflavin treatment. In addition, Theaflavin significantly diminished the ROS production of steatotic hepatocytes and TNF-α production by LPS-stimulated RAW264.7 cells.
    CONCLUSIONS:
    We concluded that Theaflavin has protective effects against I/R injury in fatty livers by anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms.
    J Lipid Res. 2007 Nov;48(11):2334-43.
    Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells.[Pubmed: 17720960 ]
    Black tea is one of the world's most popular beverages, and its health-promoting effects have been intensively investigated. The antiobesity and hypolipidemic effects of black tea have attracted increasing interest, but the mechanisms underlying these phenomena remain unclear.
    METHODS AND RESULTS:
    In the present study, the black tea major component Theaflavins were assessed for their hepatic lipid-lowering potential when administered in fatty acid overload conditions both in cell culture and in an animal experimental model. We found that Theaflavins significantly reduced lipid accumulation, suppressed fatty acid synthesis, and stimulated fatty acid oxidation. Furthermore, Theaflavins also inhibited acetyl-coenzyme A carboxylase activities by stimulating AMP-activated protein kinase (AMPK) through the LKB1 and reactive oxygen species pathways. These observations support the idea that AMPK is a critical component of decreased hepatic lipid accumulation by Theaflavin treatments.
    CONCLUSIONS:
    Our results show that Theaflavins are bioavailable both in vitro and in vivo and may be active in the prevention of fatty liver and obesity.
    Chonnam Med J. 2011 Aug;47(2):104-10.
    Theaflavin Inhibits LPS-Induced IL-6, MCP-1, and ICAM-1 Expression in Bone Marrow-Derived Macrophages Through the Blockade of NF-κB and MAPK Signaling Pathways.[Pubmed: 22111069]
    Theaflavin, the main polyphenol in black tea, has anti-inflammatory, antioxidative, anti-mutagenic, and anti-carcinogenic properties. The aim of this study was to evaluate the effects of Theaflavin on lipopolysaccharide (LPS)-induced innate signaling and expression of pro-inflammatory mediators in bone marrow-derived macrophages isolated from ICR mice.
    METHODS AND RESULTS:
    The effects of Theaflavin on the expression of proinflammatory mediators, LPS-induced nuclear factor-kappa B (NF-κB), and mitogen-activated protein kinase (MAPK) signaling pathways were examined by reverse transcriptase-polymerase chain reaction (RT-PCR), Western blotting, and immunofluorescence. LPS-induced interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and intercellular adhesion molecule-1 (ICAM-1) expression was inhibited by Theaflavin. LPS-induced inhibitor kappa B alpha (IκBα) degradation and nuclear translocation of RelA were blocked by Theaflavin. LPS-induced phosphorylation of extracellular signal-regulated kinase1/2 (ERK1/2), c-Jun-N-terminal kinase (JNK), and p38 MAPK was inhibited by Theaflavin. The inhibitory effect of Theaflavin on IL-6, MCP-1, and ICAM-1 expression was completely inhibited by Bay11-7082 (NF-κB inhibitor). The inhibitory effect of Theaflavin on IL-6 and ICAM-1 expression was inhibited by SB203580 (p38 MAPK inhibitor). The inhibitory effect of Theaflavin on MCP-1 expression was inhibited by SP600125 (JNK inhibitor).
    CONCLUSIONS:
    These results indicate that Theaflavin prevents LPS-induced IL-6, MCP-1, and ICAM-1 expression through blockade of NF-κB and MAPK signaling pathways in bone marrow-derived macrophages.
    Antiviral Res. 2015 Jun;118:56-67.
    Antiviral activity of theaflavin digallate against herpes simplex virus type 1.[Pubmed: 25818500]
    Tea is the second most consumed drink in the world. The beneficial effects of tea have been mostly attributed to its catechin content. Black tea is derived from the leaves of Camellia sinensis plant, and it is rich in Theaflavin polyphenols, in particular Theaflavin (TF1), Theaflavin-3-monogallate (TF2A), Theaflavin-3'-monogallate (TF2B), and Theaflavin-3,3'-digallate (TF3). Vero and A549 cells were used to evaluate the effect of purified individual black tea Theaflavins as anti-herpes simplex virus 1 agents. With the rise of HSV resistant strains, there is a critical need to develop novel antiherpesviral treatments.
    METHODS AND RESULTS:
    Results of the cytotoxicity assay tested by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium] showed that TF1, TF2, and TF3 are not toxic to Vero and A549 cells at a concentration up to 75 μM. The antiviral activity of the individual Theaflavins was tested by plaque reduction assay, MTS assay, flow cytometric analysis and confocal microscopy observations. The results showed that TF1, TF2, and TF3 exhibit potent, dose-dependent anti-HSV-1 effect, with TF3 being the most efficient in both Vero and A549 cells. A concentration of 50 μM TF3 and above was sufficient to inhibit >99% of the production of HSV-1 viral particles. The anti-HSV-1 effect of TF3 is due to a direct effect on the virions, and treating Vero or A549 cells with TF3 for 1h prior to infection, or treating the cells at different times post infection does not inhibit HSV-1 production.
    CONCLUSIONS:
    TF3 is stable at vaginal pH, indicating its potential to be a promising natural and affordable remedy against herpes simplex viral infections.
    Brain Res. 2012 Jan 18;1433:104-13.
    Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.[Pubmed: 22138428]
    Parkinson's disease (PD) is a progressive neurodegenerative disorder, characterized by loss of dopominergic neurons in substantia nigra pars compacta, and can be experimentally induced by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Chronic administration of MPTP/probenecid (MPTP/p) leads to oxidative stress, induction of apoptosis, and loss of dopominergic neurons which results in motor impairments. Epidemiological studies have shown an inverse relationship between tea consumption and susceptibility to PD. Theaflavin is a black tea polyphenol, which possess a wide variety of pharmacological properties including potent anti oxidative, anti apoptotic and anti inflammatory effects.
    METHODS AND RESULTS:
    The current study is aimed to assess the effect of Theaflavin against MPTP/p induced neurodegenaration in C57BL/6 mice. We found that the Theaflavin attenuates MPTP/p induced apoptosis and neurodegeneration as evidenced by increased expression of nigral tyrosine hydroxylase (TH), dopamine transporter (DAT) and reduced apoptotic markers such as caspase-3, 8, 9 accompanied by normalized behavioral characterization.
    CONCLUSIONS:
    This may be due to anti oxidative and anti apoptotic activity and these data indicate that Theaflavin may provide a valuable therapeutic strategy for the treatment of progressive neurodegenerative diseases such as PD.
    Yuankanin

    Catalog No: CFN95128
    CAS No: 77099-20-8
    Price: $318/5mg
    ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid

    Catalog No: CFN95172
    CAS No: 55483-24-4
    Price: $318/10mg
    Ginsenoside Rd2 (Quinquenoside L10)

    Catalog No: CFN95231
    CAS No: 83480-64-2
    Price: $318/10mg
    Neoarctin B

    Catalog No: CFN95243
    CAS No: 155969-67-8
    Price: $318/10mg
    (R)-5,3'-Dimethyl hesperidin

    Catalog No: CFN95310
    CAS No: N/A
    Price: $318/5mg
    Eucomic acid

    Catalog No: CFN95364
    CAS No: 42151-32-6
    Price: $368/5mg
    Baishouwubenzophenone

    Catalog No: CFN95473
    CAS No: 115834-34-9
    Price: $318/5mg
    Mahuannin J

    Catalog No: CFN95533
    CAS No: N/A
    Price: $318/5mg
    Ephedrannin D1

    Catalog No: CFN95547
    CAS No: 1592431-55-4
    Price: $318/5mg
    8-Hydroxy-5,7-dimethoxyflavanone

    Catalog No: CFN95580
    CAS No: 201230-40-2
    Price: $318/5mg